JP2021527123A5 - - Google Patents
Info
- Publication number
- JP2021527123A5 JP2021527123A5 JP2021518038A JP2021518038A JP2021527123A5 JP 2021527123 A5 JP2021527123 A5 JP 2021527123A5 JP 2021518038 A JP2021518038 A JP 2021518038A JP 2021518038 A JP2021518038 A JP 2021518038A JP 2021527123 A5 JP2021527123 A5 JP 2021527123A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- following
- linker
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862680904P | 2018-06-05 | 2018-06-05 | |
| US62/680,904 | 2018-06-05 | ||
| PCT/US2019/035652 WO2019236747A2 (en) | 2018-06-05 | 2019-06-05 | Cyclic peptide compounds and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021527123A JP2021527123A (ja) | 2021-10-11 |
| JP2021527123A5 true JP2021527123A5 (https=) | 2022-06-22 |
Family
ID=68769580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518038A Pending JP2021527123A (ja) | 2018-06-05 | 2019-06-05 | 環状ペプチド化合物およびその使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12060438B2 (https=) |
| EP (1) | EP3801592A4 (https=) |
| JP (1) | JP2021527123A (https=) |
| CA (1) | CA3102630A1 (https=) |
| WO (1) | WO2019236747A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117466788A (zh) * | 2023-10-30 | 2024-01-30 | 吉尔多肽生物制药(大连市)有限公司 | 一种Nα-叔丁氧羰基-L-半胱氨酸的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2328603A4 (en) * | 2008-08-18 | 2013-01-02 | Univ Maryland | APF DERIVATIVES AND USE METHOD |
| EP2547693B1 (en) * | 2010-03-19 | 2015-03-11 | H. Lee Moffitt Cancer Center & Research Institute | Integrin interaction inhibitors for the treatment of cancer |
| US20150071918A1 (en) * | 2012-05-09 | 2015-03-12 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Peptides for the treatment of cancer |
| US20140322227A1 (en) | 2013-04-26 | 2014-10-30 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Peptides for treatment of bone deficiency and autoimmune disorders |
| US10011635B2 (en) * | 2013-09-27 | 2018-07-03 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Cyclic peptide conjugates and methods of use |
| US10197575B2 (en) * | 2014-03-31 | 2019-02-05 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Stabilized peptoid-peptide hybrids and uses thereof |
-
2019
- 2019-06-05 WO PCT/US2019/035652 patent/WO2019236747A2/en not_active Ceased
- 2019-06-05 US US16/972,558 patent/US12060438B2/en active Active
- 2019-06-05 CA CA3102630A patent/CA3102630A1/en active Pending
- 2019-06-05 EP EP19816163.0A patent/EP3801592A4/en not_active Withdrawn
- 2019-06-05 JP JP2021518038A patent/JP2021527123A/ja active Pending
-
2024
- 2024-07-03 US US18/763,815 patent/US20250136642A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019514426A5 (https=) | ||
| FI3642340T3 (fi) | Muunneltu l-asparaginaasi | |
| HUT75708A (en) | Neurokinine (tachykinine) antagonists | |
| HUE035180T2 (hu) | Dolastatin 10 és auristatinok származékai | |
| CA2498772A1 (en) | Modified pna molecules | |
| JPH0753753B2 (ja) | タチキニン由来の新規ぺプチドおよび医薬組成物 | |
| JP2022095872A5 (https=) | ||
| JP2018509143A5 (https=) | ||
| HU228073B1 (hu) | Új dolasztatin-származékok, elõállításuk, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| ZA200309624B (en) | 3-fluoro-pyrrolidines as antidiabetic agents. | |
| JP2022504596A5 (https=) | ||
| JP2024532465A5 (https=) | ||
| JP2023522990A5 (https=) | ||
| MX2024005883A (es) | Compuesto para el secuestro de anticuerpos no deseables en un paciente. | |
| US20150202218A1 (en) | Broad Spectrum Inhibitors of the Post Proline Cleaving Enzymes for Treatment of Hepatitis C Virus Infections | |
| JP2023529839A5 (https=) | ||
| JP2017518363A5 (https=) | ||
| JPH06504055A (ja) | ヘキサーおよびヘプタペプチドのアナフィラトキシン受容体リガンド | |
| JP2021527123A5 (https=) | ||
| MX2023003377A (es) | Compuesto para aumentar la eficacia de los vectores virales. | |
| ES2233070T3 (es) | Sintesis de analogos peptidicos ciclicos modificados en el anillo. | |
| HU204069B (en) | Process for producing new spergualin derivatives and pharmaceutical compositions comprising same as active ingredient | |
| JP2025513521A5 (https=) | ||
| US7541339B2 (en) | Par-2-activating peptide derivative and pharmaceutical composition using the same | |
| JP2006523608A5 (https=) |